Back
ProShares UltraShort MSCI Emerging Markets Vs. Monopar Therapeutics Industry Stock Comparison
Sell
22
EEV
ProShares UltraShort MSCI Emerging Markets
Last Price:
$13.00
Seasonality Move:
-0.01%
Sell
39
MNPR
Monopar Therapeutics
Last Price:
$34.40
Seasonality Move:
-27.37%
Sell
22
ProShares UltraShort MSCI Emerging Markets (EEV)
is a Sell
Is ProShares UltraShort MSCI Emerging Markets a Buy, Sell or Hold?
-
The current ProShares UltraShort MSCI Emerging Markets [EEV] share price is $13.15. The Score for EEV is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
EEV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $34.51. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EEV Stock Price Chart
What is ProShares UltraShort MSCI Emerging Markets's stock price today?
-
The ProShares UltraShort MSCI Emerging Markets share price today is $13.15Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EEV is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $34.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
EEV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.24 | Sell |
Relative Strength Index (14 RSI): | 28.9 | Sell |
Chaikin Money Flow: | -10407 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.6 - 14.42) | Sell |
Bollinger Bands (100): | (14.37 - 16.97) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.86 | Sell |
Relative Strength Index (14 RSI): | 46.76 | Sell |
Chaikin Money Flow: | -2328 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.05 - 38.67) | Sell |
Bollinger Bands (100): | (31.85 - 43.25) | Sell |
EEV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.76 | Sell |
20-day SMA: | 13.86 | Sell |
50-day SMA: | 15.28 | Sell |
200-day SMA: | 16.07 | Sell |
8-day EMA: | 13.61 | Sell |
20-day EMA: | 13.94 | Sell |
50-day EMA: | 13.11 | Buy |
200-day EMA: | 6.57 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.21 | Buy |
20-day SMA: | 35.08 | Sell |
50-day SMA: | 37.01 | Sell |
200-day SMA: | 25.73 | Buy |
8-day EMA: | 34.88 | Sell |
20-day EMA: | 35.47 | Sell |
50-day EMA: | 36.28 | Sell |
200-day EMA: | 27.84 | Buy |
ProShares UltraShort MSCI Emerging Markets Earnings Growth & EEV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.11 per share.
ProShares UltraShort MSCI Emerging Markets Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |